Notice2022-24788
Advisory Council on Blood Stem Cell Transplantation
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 15, 2022
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary's Advisory Council on Blood Stem Cell Transplantation (ACBSCT) has scheduled public meetings. Information about ACBSCT and the agenda for these meetings can be found on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory- council.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 219 (Tuesday, November 15, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 219 (Tuesday, November 15, 2022)]
[Notices]
[Pages 68505-68506]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-24788]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Council on Blood Stem Cell Transplantation
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Advisory Council on Blood Stem
Cell Transplantation (ACBSCT) has scheduled public meetings.
Information about ACBSCT and the agenda for these meetings can be found
on the ACBSCT website at <a href="https://bloodstemcell.hrsa.gov/about/advisory-council">https://bloodstemcell.hrsa.gov/about/advisory-council</a>.
DATES:
<bullet> Monday, December 5, 2022, 12-4 p.m. Eastern Time; and
<bullet> Tuesday, December 6, 2022, 12-4 p.m. Eastern Time.
ADDRESSES: This meeting will be held virtually by webinar. A link to
register and join the meeting will be posted at least 10 days prior to
the meeting at <a href="https://bloodstemcell.hrsa.gov/about/advisory-council">https://bloodstemcell.hrsa.gov/about/advisory-council</a>.
FOR FURTHER INFORMATION CONTACT: Shelley Grant, Designated Federal
Official, at the HRSA's Health Systems Bureau, Division of
Transplantation, 5600 Fishers Lane, 8W-67, Rockville, Maryland 20857;
301-443-8036; or <a href="/cdn-cgi/l/email-protection#68292b2a3b2b3c203a3b2928001a1b09460f071e"><span class="__cf_email__" data-cfemail="a0e1e3e2f3e3f4e8f2f3e1e0c8d2d3c18ec7cfd6">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations
to the Secretary of Health and Human Services (Secretary) on policy,
program development, and other matters of significance concerning the
activities under the authority of 42 U.S.C. Section 274k, Section 379
of the Public Health Service Act, as amended, and Public Law 109-129,
and as amended.
During the December 5 and December 6, 2022, meetings, ACBSCT will
discuss the impact of COVID-19 on blood stem cell donation and
transplantation; unmet needs in blood stem cell transplantation and
cellular therapy; strategies to improve rates of adult blood stem
donation; and other areas to increase blood stem cell donation and
transplantation. Agenda items are subject to change as priorities
dictate. Refer to the ACBSCT website for any updated information
concerning the meeting. Members of the public will have the opportunity
to provide comments. Public participants may submit written statements
in advance of the scheduled meetings; oral comments will be honored in
the order they are requested and may be limited as time allows.
Requests to submit a written statement or make oral comments to ACBSCT
should be sent to Shelley Grant using the contact information above at
least 3 business days prior to the meeting. Individuals who plan to
[[Page 68506]]
attend and need special assistance or another reasonable accommodation
should notify ACBSCT at the address and phone number listed above at
least 10 business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-24788 Filed 11-14-22; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 15, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.